AllaChem

AllaChem is a biotechnology company specializing in the discovery and development of novel small molecule therapeutics for oncology, infectious diseases, and central nervous system disorders. The company utilizes a robust medicinal chemistry platform to identify and optimize lead compounds, transitioning them from early-stage research into clinical development. AllaChem's portfolio includes inhibitors targeting dihydroorotate dehydrogenase (DHODH) and CXCR4 antagonists, with applications ranging from viral infections like COVID-19 to hematological malignancies. In addition to its internal pipeline, the company provides specialized drug discovery services and collaborates with global pharmaceutical partners to accelerate the delivery of innovative medicines.